Masir 2010 - Mykonos

PROGRAMME

Wednesday, June 9, 2010 will be the date of arrival.  That evening will be a welcome reception.  The meeting itself begins on Thursday, June 10, and will have six scientific sessions over 4 days (Thursday morning/evening, Friday morning/early afternoon, one session on Saturday, and one session on Sunday morning).  The schedule is modeled on our previous three meetings, which have had tremendous success.  We are modifying the schedule somewhat to include a completely free morning/early afternoon on Saturday, and a morning session on Sunday, in recognition of the spectacular site of the meeting.  Providing such free time strongly encourages the very high attendance rates we have seen at our previous meetings.

Departure will be on Sunday, June 13; vendors should take down booths in the afternoon of Saturday June 12.

MASIR Scientific Organizing Committee

  • Jan Gratama (Daniel den Hoed Kliniek, Rotterdam, The Netherlands)
  • Florian Kern (Sussex University, Brighton, UK)
  • Mario Roederer (Vaccine Research Center, NIAID, NIH, Bethesda, MD, US)

List of Confirmed Speeches:

Arnie Akbar  The characterization of antigen-specific T cells during secondary immune responses in vivo
Marcus Altfeld  NK cell responses to HIV-1
Mike Betts  Novel methods to analyze and isolate human memory T cells
Dirk Busch  Plasticity of CD8+ T cell differentation and its implications for adoptive immunotherapy
Vincenzo Cerundolo  Harnessing innate immune responses to optimize vaccination strategies
Pierre Coulie  Numbers and functions of human anti-tumor T cells
Shane Crotty Follicular Helper CD4 T Cell (Tfh) Differentiation and Function
Reno Debets  TCR gene therapy to treat solid tumors: generating potent yet safe T cell responses
Deborah Dunn-Walters  Effect of age on immunoglobulin gene repertoire in response to challenge
Rong Fan  Integrated Microchips to Assess Multifunctionality of Single T Cells
Lucas Flatz  Single cell gene expression profiles identify distinct CD8+ T cell immune responses elicited by different gene-based vaccines
Beatrix Grubeck-Loebenstein  Antigen experienced CD8+ T cells in old age
Tanzina Haque  Long term outcome of adoptive immunotherapy using ex-vivo expanded Epstein-Barr virus (EBV)-specific cytotoxic T cells
Rick Koup  In vitro and in vivo evaluation of T cell functional regulation
Antonio Lanzavecchia  Dissecting the human antibody response to pathogens and vaccines
Bruce Levine Strategies for Immune Reconstitution by Adoptive Transfer of Engineered T Cells in HIV
Fabrizio Manca From a redundant repertoire to selection of specific T cells: in vivo and in vitro processes to achieve protection from infections
Markus Maurer High content MHC class II epitope and antibody recognition profiling using peptide microarrays
Matthew McCall  Immune Responses in Experimental Human Malaria Infections
Kees Melief Immunotherapy of established lesions induced by high risk HPV
Garry Nolan Using Perturbation & Homeostasis at the Single Cell Level for Mechanistic Definitions of Normality, Autoimmunity, & Cancer
Bart Roep  Detection of islet-specific autoreactive T-cells by a novel robust and high-through-put screening strategy in stored blood samples of type 1 diabetic patients
Federica Sallusto  Dissecting the human T cell response to pathogens and vaccines
Rafick Sékaly  Systems biology approaches to memory T cell development
Ludvig Sollid Gluten specific  T-cell  responses in celiac disease
Scott Tanner  Beyond 30 Parameters in Single Cells with Mass Cytometry
Max Topp Specific for Herpesviruses and Fungal Pathogens: Implications for Adoptive Immunotherapy
Theresa Whiteside  Monitoring for regulatory T cell (Treg) subsets in cancer and the prognostic value of Treg measurements
John Zaunders  Identifying, isolating and expanding antigen-specific effector and T regulatory CD4 cells